Why is Verastem, Inc. ?
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(Q) Highest at USD 40.08 MM
- RAW MATERIAL COST(Y) Fallen by -23.26% (YoY)
- CASH AND EQV(HY) Highest at USD 318.03 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -10.99%, its profits have fallen by -44.7%
- Promoters have decreased their stake in the company by -5.31% over the previous quarter and currently hold 11.16% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
- Even though the market (S&P 500) has generated returns of 15.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -10.99% returns
How much should you hold?
- Overall Portfolio exposure to Verastem, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Verastem, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 40.08 MM
Fallen by -23.26% (YoY
Highest at USD 318.03 MM
Highest at 6.7 times
Highest at USD -32.43 MM
Highest at -80.92 %
Highest at USD -32.01 MM
Highest at USD -32.83 MM
Highest at USD -0.35
Lowest at USD -162.2 MM
At USD 0.74 MM has Grown at 83.66%
Here's what is working for Verastem, Inc.
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Verastem, Inc.
Interest Paid (USD MM)
Operating Cash Flows (USD MM)






